Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription 22.04.2024 1 Ann Surg Oncol 2 Br J Dermatol 2 Int J Cancer 1 J Am Acad Dermatol 1 J Clin Invest 1 Melanoma Res 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. LEE TS, Li I, Peric B, Saw RPM, et al
   ASO Visual Abstract: Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective Randomized Trial.
   Ann Surg Oncol. 2024 Apr 18. doi: 10.1245/s10434-024-15262.
   PubMed        
   
   

   
   Br J Dermatol

2. 
   A novel strategy for the treatment of melanoma.
   Br J Dermatol. 2024;190:e51.
   PubMed        
   
   
3. 
   Targeting malignant melanoma cells expressing the protein CD20 enhances BRAF-targeted treatment.
   Br J Dermatol. 2024;190:e58.
   PubMed        
   
   

   
   Int J Cancer

4. FROHLICH LM, Villar-Miyar A, Heintze T, Sauer B, et al
   PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma.
   Int J Cancer. 2024 Apr 15. doi: 10.1002/ijc.34947.
   PubMed         Abstract available
   
   
5. KAMEI M, Matsuo K, Yoshida Y, Shimada K, et al
   Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9-expressing conventional type-1 dendritic cells.
   Int J Cancer. 2024;154:2176-2188.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

6. MONNIER J, Gouabou Foahom AC, Serdi M, Collenne J, et al
   Automated melanoma detection. An algorithm inspired from human intelligence characterizing disordered pattern of melanocytic lesions improving a convolutional neural network.
   J Am Acad Dermatol. 2024 Apr 11:S0190-9622(24)00630.
   PubMed        
   
   

   
   J Clin Invest

7. ZHAN Y, Guo J, Yang W, Goncalves C, et al
   MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.
   J Clin Invest. 2024;134:e181338.
   PubMed        
   
   

   
   Melanoma Res

8. WU LW, Tao JJ, McDonnell D, Izar B, et al
   Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition.
   Melanoma Res. 2024 Apr 18. doi: 10.1097/CMR.0000000000000974.
   PubMed         Abstract available
   
   

   
   PLoS One

9. ZHANG L, Zhang L, Zhang C, Shi S, et al
   circTADA2A inhibited SLC38A1 expression and suppresses melanoma progression through the prevention of CNBP trans-activation.
   PLoS One. 2024;19:e0301356.
   PubMed         Abstract available
   
   
10. BUJA A, Rugge M, Cozzolino C, Dossi F, et al
    Could the mitotic count improve personalized prognosis in melanoma patients?
    PLoS One. 2024;19:e0302309.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.